News

Erik Schouten

In 2011, Malawi implemented an ambitious and pioneering “test-and-treat” HIV strategy for pregnant and breastfeeding women, known as Option B+. Erik Schouten, MSH's Country Lead and Project Director of  the District Health System Strengthening and Quality Improvement for Service Delivery Project in Malawi, supported the roll-out of the program.

 {Photo credit: Wezi Tjaronda (MSH/SIAPS Namibia)}Pharmacist in charge of the Facility Electronic Stock Card (FESC) at Oshakati Hospital, Tesema Zelalem (seated) shows the US Ambassador to Namibia, Thomas Daughton (right) and Senior Pharmacist of the hospital, Mesele Walellign a print out of available medicines in the pharmacy, from the FESC computer on July 13, 2017.Photo credit: Wezi Tjaronda (MSH/SIAPS Namibia)

The U.S. Ambassador to Namibia, H.E. Thomas Daughton, visited a hospital and clinic in the Oshana region of Namibia last week to unveil a new electronic stock card, an innovation that has greatly improved service delivery in the country.

 {Photo credit: SIAPS Namibia}ART Pharmacy in Oshikuku District Hospital, Omusati Region, Namibia.Photo credit: SIAPS Namibia

In a major advance against the spread of HIV, Namibia has approved the use of Truvada to prevent HIV infection.

Pages

Printer Friendly Version